Thermo Fisher Scientific Inc.TMONYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank67
3Y CAGR-17.3%
5Y CAGR+29.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-17.3%/yr
Quarterly compound
5Y CAGR
+29.1%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 63.05% |
| Q3 2025 | 66.06% |
| Q2 2025 | 206.09% |
| Q1 2025 | -87.15% |
| Q4 2024 | 48.36% |
| Q3 2024 | 14.17% |
| Q2 2024 | 83.52% |
| Q1 2024 | -72.75% |
| Q4 2023 | 59.37% |
| Q3 2023 | 65.76% |
| Q3 2023 | 363.47% |
| Q2 2023 | -90.77% |
| Q4 2022 | 111.29% |
| Q4 2022 | 36.01% |
| Q3 2022 | -34.57% |
| Q2 2022 | -15.89% |
| Q4 2021 | -12.65% |
| Q4 2021 | 26.02% |
| Q3 2021 | 24.96% |
| Q2 2021 | -50.96% |
| Q4 2020 | 17.55% |
| Q3 2020 | 44.84% |
| Q2 2020 | 1469.90% |
| Q1 2020 | -93.66% |
| Q4 2019 | 80.24% |
| Q3 2019 | -16.11% |
| Q2 2019 | 139.73% |
| Q1 2019 | -70.47% |
| Q4 2018 | 44.89% |
| Q3 2018 | -16.97% |
| Q2 2018 | 3252.50% |
| Q1 2018 | -102.42% |
| Q4 2017 | 102.07% |
| Q3 2017 | 7.47% |
| Q3 2017 | 183.63% |
| Q2 2017 | -75.00% |
| Q4 2016 | 55.24% |
| Q4 2016 | -10.83% |
| Q3 2016 | 345.23% |
| Q2 2016 | -84.16% |